Cargando…

An automated retrospective VAE-surveillance tool for future quality improvement studies

Ventilator-associated pneumonia (VAP) is a frequent complication of mechanical ventilation and is associated with substantial morbidity and mortality. Accurate diagnosis of VAP relies in part on subjective diagnostic criteria. Surveillance according to ventilator-associated event (VAE) criteria may...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolffers, Oliver, Faltys, Martin, Thomann, Janos, Jakob, Stephan M., Marschall, Jonas, Merz, Tobias M., Sommerstein, Rami
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593155/
https://www.ncbi.nlm.nih.gov/pubmed/34782637
http://dx.doi.org/10.1038/s41598-021-01402-3
_version_ 1784599657910894592
author Wolffers, Oliver
Faltys, Martin
Thomann, Janos
Jakob, Stephan M.
Marschall, Jonas
Merz, Tobias M.
Sommerstein, Rami
author_facet Wolffers, Oliver
Faltys, Martin
Thomann, Janos
Jakob, Stephan M.
Marschall, Jonas
Merz, Tobias M.
Sommerstein, Rami
author_sort Wolffers, Oliver
collection PubMed
description Ventilator-associated pneumonia (VAP) is a frequent complication of mechanical ventilation and is associated with substantial morbidity and mortality. Accurate diagnosis of VAP relies in part on subjective diagnostic criteria. Surveillance according to ventilator-associated event (VAE) criteria may allow quick and objective benchmarking. Our objective was to create an automated surveillance tool for VAE tiers I and II on a large data collection, evaluate its diagnostic accuracy and retrospectively determine the yearly baseline VAE incidence. We included all consecutive intensive care unit admissions of patients with mechanical ventilation at Bern University Hospital, a tertiary referral center, from January 2008 to July 2016. Data was automatically extracted from the patient data management system and automatically processed. We created and implemented an application able to automatically analyze respiratory and relevant medication data according to the Centers for Disease Control protocol for VAE-surveillance. In a subset of patients, we compared the accuracy of automated VAE surveillance according to CDC criteria to a gold standard (a composite of automated and manual evaluation with mediation for discrepancies) and evaluated the evolution of the baseline incidence. The study included 22′442 ventilated admissions with a total of 37′221 ventilator days. 592 ventilator-associated events (tier I) occurred; of these 194 (34%) were of potentially infectious origin (tier II). In our validation sample, automated surveillance had a sensitivity of 98% and specificity of 100% in detecting VAE compared to the gold standard. The yearly VAE incidence rate ranged from 10.1–22.1 per 1000 device days and trend showed a decrease in the yearly incidence rate ratio of 0.96 (95% CI, 0.93–1.00, p = 0.03). This study demonstrated that automated VAE detection is feasible, accurate and reliable and may be applied on a large, retrospective sample and provided insight into long-term institutional VAE incidences. The surveillance tool can be extended to other centres and provides VAE incidences for performing quality control and intervention studies.
format Online
Article
Text
id pubmed-8593155
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-85931552021-11-17 An automated retrospective VAE-surveillance tool for future quality improvement studies Wolffers, Oliver Faltys, Martin Thomann, Janos Jakob, Stephan M. Marschall, Jonas Merz, Tobias M. Sommerstein, Rami Sci Rep Article Ventilator-associated pneumonia (VAP) is a frequent complication of mechanical ventilation and is associated with substantial morbidity and mortality. Accurate diagnosis of VAP relies in part on subjective diagnostic criteria. Surveillance according to ventilator-associated event (VAE) criteria may allow quick and objective benchmarking. Our objective was to create an automated surveillance tool for VAE tiers I and II on a large data collection, evaluate its diagnostic accuracy and retrospectively determine the yearly baseline VAE incidence. We included all consecutive intensive care unit admissions of patients with mechanical ventilation at Bern University Hospital, a tertiary referral center, from January 2008 to July 2016. Data was automatically extracted from the patient data management system and automatically processed. We created and implemented an application able to automatically analyze respiratory and relevant medication data according to the Centers for Disease Control protocol for VAE-surveillance. In a subset of patients, we compared the accuracy of automated VAE surveillance according to CDC criteria to a gold standard (a composite of automated and manual evaluation with mediation for discrepancies) and evaluated the evolution of the baseline incidence. The study included 22′442 ventilated admissions with a total of 37′221 ventilator days. 592 ventilator-associated events (tier I) occurred; of these 194 (34%) were of potentially infectious origin (tier II). In our validation sample, automated surveillance had a sensitivity of 98% and specificity of 100% in detecting VAE compared to the gold standard. The yearly VAE incidence rate ranged from 10.1–22.1 per 1000 device days and trend showed a decrease in the yearly incidence rate ratio of 0.96 (95% CI, 0.93–1.00, p = 0.03). This study demonstrated that automated VAE detection is feasible, accurate and reliable and may be applied on a large, retrospective sample and provided insight into long-term institutional VAE incidences. The surveillance tool can be extended to other centres and provides VAE incidences for performing quality control and intervention studies. Nature Publishing Group UK 2021-11-15 /pmc/articles/PMC8593155/ /pubmed/34782637 http://dx.doi.org/10.1038/s41598-021-01402-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Wolffers, Oliver
Faltys, Martin
Thomann, Janos
Jakob, Stephan M.
Marschall, Jonas
Merz, Tobias M.
Sommerstein, Rami
An automated retrospective VAE-surveillance tool for future quality improvement studies
title An automated retrospective VAE-surveillance tool for future quality improvement studies
title_full An automated retrospective VAE-surveillance tool for future quality improvement studies
title_fullStr An automated retrospective VAE-surveillance tool for future quality improvement studies
title_full_unstemmed An automated retrospective VAE-surveillance tool for future quality improvement studies
title_short An automated retrospective VAE-surveillance tool for future quality improvement studies
title_sort automated retrospective vae-surveillance tool for future quality improvement studies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593155/
https://www.ncbi.nlm.nih.gov/pubmed/34782637
http://dx.doi.org/10.1038/s41598-021-01402-3
work_keys_str_mv AT wolffersoliver anautomatedretrospectivevaesurveillancetoolforfuturequalityimprovementstudies
AT faltysmartin anautomatedretrospectivevaesurveillancetoolforfuturequalityimprovementstudies
AT thomannjanos anautomatedretrospectivevaesurveillancetoolforfuturequalityimprovementstudies
AT jakobstephanm anautomatedretrospectivevaesurveillancetoolforfuturequalityimprovementstudies
AT marschalljonas anautomatedretrospectivevaesurveillancetoolforfuturequalityimprovementstudies
AT merztobiasm anautomatedretrospectivevaesurveillancetoolforfuturequalityimprovementstudies
AT sommersteinrami anautomatedretrospectivevaesurveillancetoolforfuturequalityimprovementstudies
AT wolffersoliver automatedretrospectivevaesurveillancetoolforfuturequalityimprovementstudies
AT faltysmartin automatedretrospectivevaesurveillancetoolforfuturequalityimprovementstudies
AT thomannjanos automatedretrospectivevaesurveillancetoolforfuturequalityimprovementstudies
AT jakobstephanm automatedretrospectivevaesurveillancetoolforfuturequalityimprovementstudies
AT marschalljonas automatedretrospectivevaesurveillancetoolforfuturequalityimprovementstudies
AT merztobiasm automatedretrospectivevaesurveillancetoolforfuturequalityimprovementstudies
AT sommersteinrami automatedretrospectivevaesurveillancetoolforfuturequalityimprovementstudies